Open Orphan - Completion of Acquisition
ORPH
Wed, 15 Jan 2020, 07:00 GMT
Open Orphan was founded in 2017, with the goal of becoming Europe’s leading rare disease and orphan drug-focused pharma services company by a management team with extensive industry and financial expertise.
Industry: Health Care
Contact: +353 (01) 6440007
Dublin 2, Ireland
https://www.openorphan.com
Cathal Friel, Chief Executive of Open Orphan, discusses the acquisition of hVIVO including the deal itself, management team, and synergies with Open Orphan. hVIVO is a differentiated clinical development services business pioneering human disease models based upon viral challenge and leading the way in the use of human challenge studies to establish early proof-of-concept.
